Showing results (81-90 of 696) with videos related to
Sort By:
Pageof 70
Journal of Diabetes and Its Complications|May 1, 2020
Lipoprotein(a)and renal function decline, cardiovascular disease and mortality in type 2 diabetes and microalbuminuriaNiels Sondergaard Heinrich, Bernt Johan von Scholten, Henrik Reinhard, et al.Acta Diabetologica|August 15, 2018
Urinary tubular biomarkers as predictors of kidney function decline, cardiovascular events and mortality in microalbuminuric type 2 diabetic patientsViktor Rotbain Curovic, Tine W Hansen, Mie K Eickhoff, et al.Diabetes Care|April 2, 2011
Long-term effects of Irbesartan treatment and smoking on nucleic acid oxidation in patients with type 2 diabetes and microalbuminuria: an Irbesartan in patients with type 2 diabetes and Microalbuminuria (IRMA 2) substudyKasper Broedbaek, Trine Henriksen, Allan Weimann, et al.Clinical Journal of the American Society of Nephrology : CJASN|October 13, 2017
Pooled Analysis of Multiple Crossover Trials To Optimize Individual Therapy Response to Renin-Angiotensin-Aldosterone System InterventionSergei I Petrykiv, Gozewijn Dirk Laverman, Frederik Persson, et al.Diabetes Care|January 29, 2021
A Validated Prediction Model for End-Stage Kidney Disease in Type 1 DiabetesDorte Vistisen, Gregers S Andersen, Adam Hulman, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 5, 2011
Elevated NT-proBNP and coronary calcium score in relation to coronary artery disease in asymptomatic type 2 diabetic patients with elevated urinary albumin excretion rateHenrik Reinhard, Peter R Hansen, Frederik Persson, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 28, 2020
Copeptin and renal function decline, cardiovascular events and mortality in type 1 diabetesNiels S Heinrich, Simone Theilade, Signe A Winther, et al.Kidney International Reports|February 12, 2024
Randomized Trial of SGLT2 Inhibitor Identifies Target Proteins in Diabetic Kidney DiseaseTarunveer S Ahluwalia, Teemu K E Rönkkö, Mie K Eickhoff, et al.Renal Failure|May 25, 2026
Complication rates of 16- and 18-gauge needles for native kidney biopsies: a systematic review and proportional meta-analysisMarie Møller, Tue H Andersen, Rikke Borg, et al.Scientific Reports|July 27, 2021
Faecal biomarkers in type 1 diabetes with and without diabetic nephropathySigne Abitz Winther, Miia Maininki Mannerla, Marie Frimodt-Møller, et al.Pageof 70